Neurons: Basic unit of the nervous system
Receive, integrate, and transmit information
Glial cells: Support and protect neurons
Astrocytes, microglia, oligodendrocytes (CNS), Schwann cells (PNS)
Dendrites: Receive information
Cell body (soma): Integrates information
Axon: Conducts information
Axon terminals: Release neurotransmitters
Junction between neurons
Includes presynaptic membrane, synaptic cleft, postsynaptic membrane
Electrical: Within neuron
Chemical: Between neurons (neurotransmitters)
Central Nervous System (CNS): Brain and spinal cord
Peripheral Nervous System (PNS): Cranial and spinal nerves
Somatic (voluntary)
Autonomic (involuntary): Sympathetic (fight or flight), Parasympathetic (rest and digest)
Difference in electrical charge across the membrane
Inside is negative relative to outside
Maintained by sodium-potassium pump (3 Na+ out, 2 K+ in)
Rapid reversal of membrane potential
All-or-none response
Threshold of excitation (~-40mV)
Phases: Depolarization, Repolarization, Hyperpolarization
Arrival of action potential at axon terminal causes release of neurotransmitter
Neurotransmitter binds to receptors on postsynaptic membrane
Types: Ionotropic (fast), Metabotropic (slow)
Examples: Acetylcholine, Dopamine, Serotonin, GABA, Glutamate
Cholinergic (Acetylcholine): Learning, memory
Dopaminergic: Motor control, reward
Noradrenergic: Alertness
Serotonergic: Mood, sleep
Agonists: Enhance neurotransmitter action
Antagonists: Block neurotransmitter action
Peptide, Amine, Steroid
Pituitary (master gland), adrenal, thyroid, gonads
HPA axis: Hypothalamus → Pituitary → Adrenal cortex → Cortisol
Neurogenesis, Cell migration, Differentiation, Synaptogenesis, Neuronal cell death, Synapse rearrangement
Genetics, Environment, Experience
Labeled lines, Receptor cells, Sensory transduction
Touch: Merkel’s discs, Meissner’s corpuscles, Pacinian corpuscles, Ruffini’s endings
Pain: Nociceptors, A-delta fibers (fast), C fibers (slow)
Pain modulation: Endogenous opioids
Outer, middle, inner ear
Cochlea: Hair cells, basilar membrane
Auditory pathways: Cochlear nuclei, superior olivary nuclei, inferior colliculus, medial geniculate nucleus, auditory cortex
Semicircular canals, otolith organs
Papillae, taste buds
Five basic tastes: Sweet, sour, salty, bitter, umami
Olfactory epithelium, olfactory bulb
Suprachiasmatic nucleus (SCN): Circadian clock, receives direct light information (from ganglion cells)
Lesions eliminate circadian rhythms
Transplant experiment: when adult hampsters received a transplant of SCN tissue from a donor hamster, the recipients adopted the donor's circadian rhythm, demonstrating the SCN's critical role in regulating these biological cycles.
Retinohypothalamic pathway: Specialized retinal ganglion cells → send light information → SCN
Melatonin: Secreted by pineal gland at night
Alert, awake: Desynchronized EEG
Non-REM sleep
Stage 1: Vertex spikes
note: reticular formation
Stage 2: Sleep spindles
Stage 3 (SWS): Delta waves
note: basal forebrain
REM sleep: Paradoxical sleep
note: pons
Orexin: A lack of orexin, which helps keep us awake, causes narcolepsy with extreme sleepiness and sudden sleep attacks
Sleep apnea: when breathing stops and starts during sleep, causing poor rest. It can be caused by a blocked airway or brain issues
REM behavior disorder (RBD): people act out their dreams during sleep, sometimes with violent movements
Basal forebrain: Promotes slow-wave sleep (SWS) and helps initiate deep sleep by releasing acetylcholine
Hypothalamus (VLPO): Sends GABA to arousal centers; regulates the sleep-wake cycle and circadian rhythms
Reticular formation: Regulates wakefulness and helps control the transition between sleep and wake states, maintaining alertness
Pons: key role in REM sleep and controls muscle paralysis during REM to prevent acting out dreams
Molecular clock steps
Clock/Bmal1 dimers promote the transcription of Per and Cry genes.
Per and Cry proteins interact with tau proteins to form Per/Cry/tau complexes.
These complexes inhibit the Clock/Bmal1 dimers, halting the transcription of new Per and Cry proteins.
Per, Cry, and tau proteins degrade over 24 hours, resetting the cycle.
The process is influenced by melanopsin in the retina, which sends light information to the SCN, helping synchronize the cycle with the environment.
Glutamate activation in the SCN helps maintain and regulate the cycle
Brain-self stimulation: Electrical stimulation (septum)
Fear conditioning: Neutral stimulus + unpleasant stimulus → fear response
Polygraph test: Measures heart rate, blood pressure
Relaxation training: Mindfulness-based stress reduction (MBSR)
Capgras delusion: Believe loved ones are impostors (low-road connection damage)
Maternal aggression: Mother defending offspring
Decorticate (sham) rage: Sudden rage without clear direction
Klüver-Bucy syndrome: Reduced fear/anxiety (bilateral amygdala damage)
Adrenal medulla: Releases epinephrine (E) & norepinephrine (NE)
HPA axis: Hypothalamus → anterior pituitary → adrenal cortex
ACTH → adrenal corticosteroids (e.g., cortisol)
Glucocorticoid receptors: Respond to cortisol, form stress/fear memories
FAST: Hypothalamus → adrenal medulla → E & NE
SLOW: Hypothalamus → CRH → anterior pituitary → ACTH → adrenal cortex → cortisol
Amygdala activity increases
PFC activity decreases
Folk psychology: Emotion → autonomic arousal
James-Lange: Autonomic arousal → emotion
Facial feedback hypothesis: Sensory feedback from facial expressions affects mood (James-Lange theory)
Cannon-Bard: Simultaneous emotion & arousal
Schachter-Singer Theory (Two-Factor Theory of Emotion): Perception + arousal → emotion
Experiment (1962):
Epinephrine (uninformed): Increased emotional response
Epinephrine (informed): No increase in emotional response
Participants' emotions matched the context (happy or angry), showing that interpretation of arousal influenced emotion.
Low Road (Fast): Thalamus → Amygdala (Lateral Nucleus). Quick, unconscious emotional reactions.
High Road (Slow): Thalamus → Sensory Cortex → Amygdala. Slower, conscious evaluation.
Lateral Nucleus: Main input region of the amygdala, receives sensory info.
Central Nucleus: Main output region, triggers emotional responses (via hypothalamus and brainstem).
Key cortical areas modulating emotion:
Insula: Bodily awareness and emotional feelings.
Cingulate Cortex: Emotional regulation and attention.
Prefrontal Cortex (PFC): Interprets and regulates emotional responses
Psychopathology: The study of mental disorders, including their symptoms, etiology (origins), and treatment.
Criteria for diagnosis often include distress, dysfunction, and deviance.
Schizophrenia Spectrum Disorders
Characterized by psychosis, hallucinations, delusions, disorganized thinking.
Mood Disorders
Includes depression and bipolar disorder.
Anxiety Disorders
Includes generalized anxiety, panic disorder, phobias.
Obsessive-Compulsive and Related Disorders
Includes OCD, body dysmorphic disorder.
Trauma- and Stressor-Related Disorders
Includes PTSD and acute stress disorder.
Dopamine Hypothesis: Overactivity of dopamine pathways (particularly D2 receptors) contributes to positive symptoms.
Glutamate Hypothesis: NMDA receptor hypofunction may contribute to cognitive symptoms.
Structural Abnormalities:
Enlarged ventricles
Reduced hippocampus, amygdala, and thalamus volumes
Hypofrontality: Reduced activity in the frontal lobes.
Monoamine Hypothesis: Depression results from deficits in serotonin, norepinephrine, and/or dopamine.
HPA Axis Dysregulation: Elevated cortisol levels linked to depression.
Brain Changes:
Reduced hippocampal volume
Increased amygdala activity
Bipolar Disorder: Alternating periods of mania and depression; may involve dysregulated dopamine signaling.
Amygdala Hyperactivity: Increased fear responses.
GABAergic Dysfunction: Reduced inhibitory neurotransmission may underlie anxiety.
Treatment:
Benzodiazepines enhance GABA activity.
SSRIs increase serotonin availability.
Amygdala: Hyperresponsive to trauma cues.
PFC: Hypoactivity may fail to inhibit fear responses.
Hippocampus: Reduced volume may impair context processing.
Treatment: CBT, exposure therapy, SSRIs.
Cortico-striato-thalamo-cortical (CSTC) circuit dysfunction
Serotonin Hypothesis: SSRIs are effective treatments.
Pharmacotherapy:
Antipsychotics (e.g., D2 antagonists)
Antidepressants (SSRIs, MAOIs, tricyclics)
Mood stabilizers (e.g., lithium)
Anxiolytics (e.g., benzodiazepines)
Psychotherapy:
Cognitive Behavioral Therapy (CBT)
Exposure therapy
Neuromodulation:
Electroconvulsive Therapy (ECT)
Transcranial Magnetic Stimulation (TMS)
Declarative (Explicit) Memory: Facts and events; consciously recalled
Episodic memory: Personal experiences (e.g., first day of school)
Semantic memory: Factual knowledge (e.g., capital cities)
Nondeclarative (Implicit) Memory: Skills and habits; does not require conscious thought
Procedural memory: Motor skills (e.g., riding a bike)
Priming: Exposure to one stimulus influences response to another
Conditioning: Classical and operant learning associations
Hippocampus: Critical for consolidation of declarative memories; spatial memory (place cells)
Amygdala: Emotional memory; fear conditioning
Cerebellum: Procedural learning, motor memory, classical conditioning
Prefrontal Cortex (PFC): Working memory, decision making
Mammillary bodies and Thalamus: Memory relay; implicated in Korsakoff’s syndrome
Encoding: Converting sensory input into a form that can be stored
Consolidation: Stabilization of memory traces (sleep plays a key role)
Storage: Retention of information over time
Retrieval: Accessing stored information when needed
Reconsolidation: Memories become unstable when retrieved and need to be restabilized
Persistent strengthening of synapses based on recent activity
Found primarily in the hippocampus
Involves NMDA and AMPA receptors
Basis for synaptic plasticity and memory formation
Amnesia
Retrograde amnesia: Loss of pre-existing memories
Anterograde amnesia: Inability to form new memories (e.g., H.M.)
Korsakoff’s Syndrome: Thiamine deficiency; damages mammillary bodies; severe anterograde amnesia and confabulation
Alzheimer’s Disease: Progressive loss of memory; neurofibrillary tangles and amyloid plaques
Symptoms:
Positive: Hallucinations, delusions
Negative: Flat affect, social withdrawal
Dopamine Hypothesis: Overactivity of dopamine, especially at D2 receptors.
Treatments: Antipsychotics (D2 antagonists)
Monoamine Hypothesis: Low levels of serotonin, norepinephrine, or dopamine.
HPA Axis Dysfunction: Elevated cortisol linked to depressive symptoms.
Treatments:
Antidepressants: SSRIs, MAOIs, tricyclics
Electroconvulsive Therapy (ECT)
Cognitive Behavioral Therapy (CBT)
Types: Generalized anxiety, panic disorder, phobias
Mechanisms:
Amygdala hyperactivity
GABAergic dysfunction
Treatments:
Benzodiazepines (enhance GABA)
SSRIs
CBT
Core features: Social communication deficits, restricted/repetitive behaviors.
Associated with: Theory of mind deficits, sensory sensitivities.
Symptoms: Inattention, hyperactivity, impulsivity.
Neurobiology: Dopamine dysregulation in frontal-striatal circuits.
Treatments: Stimulants (e.g., methylphenidate), behavioral interventions.
Symptoms: Re-experiencing trauma, avoidance, hyperarousal.
Neural basis: Amygdala hyperactivity, reduced PFC regulation, hippocampal atrophy.
Treatments: CBT (exposure therapy), SSRIs
Social communication deficits, restricted interests
Theory of mind deficits
Inattention, hyperactivity, impulsivity
Treatments: Stimulants (methylphenidate)
Re-experiencing trauma
Hyperarousal
Treatments: Cognitive-behavioral therapy (CBT), SSRIs